These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
219 related articles for article (PubMed ID: 36950944)
1. Synthesis and anti-prion aggregation activity of acylthiosemicarbazide analogues. Kim DH; Kim J; Lee H; Lee D; Im SM; Kim YE; Yoo M; Cheon YP; Bartz JC; Son YJ; Choi EK; Kim YS; Jeon JH; Kim HS; Lee S; Ryou C; Nam TG J Enzyme Inhib Med Chem; 2023 Dec; 38(1):2191164. PubMed ID: 36950944 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein. Kim DH; Lee HM; Ryou C J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058 [TBL] [Abstract][Full Text] [Related]
3. Applications of the real-time quaking-induced conversion assay in diagnosis, prion strain-typing, drug pre-screening and other amyloidopathies. Candelise N; Schmitz M; Da Silva Correia SM; Arora AS; Villar-Piqué A; Zafar S; Llorens F; Cramm M; Zerr I Expert Rev Mol Diagn; 2017 Oct; 17(10):897-904. PubMed ID: 28817974 [TBL] [Abstract][Full Text] [Related]
4. Recent advances in the histo-molecular pathology of human prion disease. Baiardi S; Rossi M; Capellari S; Parchi P Brain Pathol; 2019 Mar; 29(2):278-300. PubMed ID: 30588685 [TBL] [Abstract][Full Text] [Related]
6. The first non-prion pathogen identified: neurotropic influenza virus. Sakaguchi S; Hara H Prion; 2022 Dec; 16(1):1-6. PubMed ID: 34978525 [TBL] [Abstract][Full Text] [Related]
7. A simple in vitro assay for assessing the efficacy, mechanisms and kinetics of anti-prion fibril compounds. Ladner-Keay CL; Ross L; Perez-Pineiro R; Zhang L; Bjorndahl TC; Cashman N; Wishart DS Prion; 2018; 12(5-6):280-300. PubMed ID: 30223704 [TBL] [Abstract][Full Text] [Related]
8. The engineered peptide construct NCAM1-Aβ inhibits fibrillization of the human prion protein (PrP). Gielnik M; Zhukova L; Zhukov I; Gräslund A; Kozak M; Wärmländer S Acta Biochim Pol; 2022 Feb; 69(1):257-261. PubMed ID: 35143147 [TBL] [Abstract][Full Text] [Related]
9. PrP P102L and Nearby Lysine Mutations Promote Spontaneous Kraus A; Raymond GJ; Race B; Campbell KJ; Hughson AG; Anson KJ; Raymond LD; Caughey B J Virol; 2017 Nov; 91(21):. PubMed ID: 28835493 [TBL] [Abstract][Full Text] [Related]
10. Analyses of protease resistance and aggregation state of abnormal prion protein across the spectrum of human prions. Saverioni D; Notari S; Capellari S; Poggiolini I; Giese A; Kretzschmar HA; Parchi P J Biol Chem; 2013 Sep; 288(39):27972-85. PubMed ID: 23897825 [TBL] [Abstract][Full Text] [Related]
11. Innovative Non-PrP-Targeted Drug Strategy Designed to Enhance Prion Clearance. Colini Baldeschi A; Zattoni M; Vanni S; Nikolic L; Ferracin C; La Sala G; Summa M; Bertorelli R; Bertozzi SM; Giachin G; Carloni P; Bolognesi ML; De Vivo M; Legname G J Med Chem; 2022 Jul; 65(13):8998-9010. PubMed ID: 35771181 [TBL] [Abstract][Full Text] [Related]
12. Aggresome formation by mutant prion proteins: the unfolding role of proteasomes in familial prion disorders. Mishra RS; Bose S; Gu Y; Li R; Singh N J Alzheimers Dis; 2003 Feb; 5(1):15-23. PubMed ID: 12590162 [TBL] [Abstract][Full Text] [Related]
13. Validation of Poly(Propylene Imine) Glycodendrimers Towards Their Anti-prion Conversion Efficiency. Schmitz M; Candelise N; Kanata E; Llorens F; Thüne K; Villar-Piqué A; da Silva Correia SM; Dafou D; Sklaviadis T; Appelhans D; Zerr I Mol Neurobiol; 2020 Apr; 57(4):1863-1874. PubMed ID: 31848935 [TBL] [Abstract][Full Text] [Related]
16. Virus Infection, Genetic Mutations, and Prion Infection in Prion Protein Conversion. Hara H; Sakaguchi S Int J Mol Sci; 2021 Nov; 22(22):. PubMed ID: 34830321 [TBL] [Abstract][Full Text] [Related]
17. Role of prion protein glycosylation in replication of human prions by protein misfolding cyclic amplification. Camacho MV; Telling G; Kong Q; Gambetti P; Notari S Lab Invest; 2019 Nov; 99(11):1741-1748. PubMed ID: 31249376 [TBL] [Abstract][Full Text] [Related]
18. The N-Terminal Polybasic Region of Prion Protein Is Crucial in Prion Pathogenesis Independently of the Octapeptide Repeat Region. Das NR; Miyata H; Hara H; Chida J; Uchiyama K; Masujin K; Watanabe H; Kondoh G; Sakaguchi S Mol Neurobiol; 2020 Feb; 57(2):1203-1216. PubMed ID: 31707632 [TBL] [Abstract][Full Text] [Related]
19. In Vitro Seeding Activity of Glycoform-Deficient Prions from Variably Protease-Sensitive Prionopathy and Familial CJD Associated with PrP Wang Z; Yuan J; Shen P; Abskharon R; Lang Y; Dang J; Adornato A; Xu L; Chen J; Feng J; Moudjou M; Kitamoto T; Lee HG; Kim YS; Langeveld J; Appleby B; Ma J; Kong Q; Petersen RB; Zou WQ; Cui L Mol Neurobiol; 2019 Aug; 56(8):5456-5469. PubMed ID: 30612334 [TBL] [Abstract][Full Text] [Related]